👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

Stada receives 3.6 billion euro offer from private equity group Cinven: FT

Published 02/12/2017, 02:27 PM
Updated 02/12/2017, 02:30 PM
© Reuters. Logo of the pharmaceutical company Stada Arzneimittel AG is pictured at its headquarters in Bad Vilbel
NOVN
-
STAGn
-

(Reuters) - German generic drugmaker Stada (DE:STAGn) has received a 3.6 billion euro ($3.83 billion) takeover offer from private equity group Cinven, the Financial Times reported.

Cinven's offer follows a year-long activist campaign to improve Stada's profitability by Active Ownership Capital, one of its largest shareholders, and is believed to be pitched at close to 58 euros a share, the Financial Times reported, citing sources.

Cinven declined to comment. Stada was not immediately available to comment.

Advent, Bain Capital, CVC and Permira are all assessing the bidding war closely and could make a bid, the FT sources said.

In August last year, Stada's CEO Matthias Wiedenfels promised a more modern, dynamic approach to running the company, saying it had to improve its transparency, flexibility, hierarchies and communication, although it had no need to change its strategy.

AOC put forward four candidates for Stada's supervisory board for election at the AGM, including former Novartis (S:NOVN) manager Eric Cornut for chairman, and said it also supported two of the four candidates proposed by Stada.

© Reuters. Logo of the pharmaceutical company Stada Arzneimittel AG is pictured at its headquarters in Bad Vilbel

Another activist investor, Guy Wyser-Pratte, who has a stake of just under 3 percent, said in July that buyout firm CVC Capital Partners was interested in buying the drugmaker and that would be a better plan than AOC's suggested board overhaul.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.